Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunoGen, Inc. | Director | Deferred Share Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
ImmunoGen, Inc. | Director | Restricted Stock Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
AMARIN CORP PLC\UK | Director | Stock Option (Right to Buy) | 116K | Jun 27, 2022 | Direct | ||
AMARIN CORP PLC\UK | Director | Restricted Stock Units | 93.8K | Jun 27, 2022 | Direct | ||
ArriVent Biopharma, Inc. | Director | Stock Option (right to buy) | 28.6K | Apr 22, 2024 | Direct | ||
ENANTA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 15.7K | Mar 6, 2024 | Direct | ||
Immunocore Holdings plc | Director | Share Option (Right to Buy) | 14.5K | May 23, 2024 | Direct | ||
ImmunoGen, Inc. | Director | Common Stock | 0 | $29.64 | Nov 30, 2023 | Direct | |
ImmunoGen, Inc. | Director | Stock Option (Right to Buy) | 0 | $4.56 | Feb 12, 2024 | Direct | |
Paratek Pharmaceuticals, Inc. | Director | Common Stock | 0 | $2.20 | Sep 21, 2023 | Direct | |
Paratek Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 0 | Sep 21, 2023 | Direct |